First Aim

Second Aim

Third Aim

Fourth Aim

Fifth Aim

References

Membership of the Consortium is Open to...

Membership Requires

The Membership Committee is Made Up of...

Arizona, USA

Barcelona, Spain

Boston, USA

Cesena, Italy

Evry, France

FICHE D’INFORMATION AUX APPARENTES

FICHE D’INFORMATION AUX PATIENTS

Genoa, Italy

Glasgow, Scotland

Leeds, England

Professor Timothy Bishop

Julia Newton-Bishop

Jennifer Helen Barrett

Leiden, Netherlands (Department of Clinical Genetics)

Leiden, Netherlands (Department of Dermatology)

Leiden, Netherlands (ServiceXS)

Ljubljana, Slovenia

London, England

Lund, Sweden

Maryland, USA

Philadelphia, USA

Queensland, Australia

Riga, Latvia

Stockholm, Sweden

Sydney, Australia

Szczecin, Poland

Tel-Aviv, Israel

A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families

Toronto, Canada

Utah, USA

Chairman: Professor Julia Newton Bishop

GenoMEL Publications

Publications by Timothy Bishop

Rare High Penetrance Genes for Melanoma

Low Penetrance Susceptibility Genes

Assessing the Signficance of a Family History of Melanoma in the Clinic

Counselling Families About Risk

What is the Penetrance of High Penetrance Genes?

What Advice Should We Give Specifically About Moles?

What Sould We Say About Sun Avoidance?

What About Gene Testing for CDKN2A Mutations?

This section is for families who suspect or have been counseled that their family is indeed at increased risk of melanoma.

In estimating the risk to family members then doctors will look for signs of high-risk genes in the family. So, what are those signs?

What would the clinical geneticist do?

What genes cause melanoma?

What about gene testing?

Information for families with melanoma?

Leeds group newsletter